UNC Lineberger Comprehensive Cancer Center clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 424 studies whose lead sponsor is UNC Lineberger Comprehensive Cancer Center. 96 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the UNC Lineberger Comprehensive Cancer Center studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions UNC Lineberger Comprehensive Cancer Center leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Breast Neoplasms72Neoplasms49Lung Neoplasms27Lymphoma23Leukemia22Head and Neck Neoplasms20Multiple Myeloma18Colorectal Neoplasms17Prostatic Neoplasms17Endometrial Neoplasms16Uterine Cervical Neoplasms16Carcinoma, Squamous Cell14Urinary Bladder Neoplasms14Carcinoma13Carcinoma, Non-Small-Cell Lung13Pancreatic Neoplasms12Squamous Cell Carcinoma of Head and Neck12Neoplasm Metastasis11Leukemia, Myeloid, Acute10
Studies
Recruiting first, then most recently updated. Showing 50 of 424. Browse all 424 →
- Pilot Study of Communication for Dual Users of Cigarettes and E-cigarettesRecruitingNCT07599462Not applicable
- UNC Pleural Fluid RegistryRecruitingNCT05620329
- Lucid BE Biomarkers StudyNot yet recruitingNCT07887568
- The PharmFIT StudyNot yet recruitingNCT06656936Not applicable
- C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United StatesNot yet recruitingNCT07520188
- Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in Endometrial CancerNot yet recruitingNCT07867002Phase 3
- Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported XerostomiaRecruitingNCT07278557Phase 2
- BLinatumomab and iNKT in Relapsed B-Cell ALLNot yet recruitingNCT07869368Phase 1
- The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled StudyRecruitingNCT04700527Phase 1/2
- XL092 and Cemiplimab in BRAF WT Thyroid CancerRecruitingNCT06902376Phase 1
- Tirzepatide in Obesity-Driven Endometrial CancerRecruitingNCT07065552Early Phase 1
- Hyaluronic Acid-based Gel Spacers in Gynecologic MalignanciesRecruitingNCT07292818Phase 1
- Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South AfricaRecruitingNCT05413798Not applicable
- NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) MelanomaRecruitingNCT07740941Phase 2
- Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among CliniciansRecruitingNCT05440929
- Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial CancerNot yet recruitingNCT07078838Phase 2
- CD30 CAR for Relapsed/Refractory CD30+ T Cell LymphomaRecruitingNCT04083495Phase 2
- Evaluation of Impact of AI Assistance on Workload Associated w Preparation of Rare Tumor Case ReptsNot yet recruitingNCT06026098Not applicable
- Study of Trilaciclib and LurbinectidinRecruitingNCT05578326Phase 2
- Evolutionary Clinical Trial for Novel Biomarker-Driven TherapiesRecruitingNCT07340541Phase 2
- Feasibility Pilot of AYA-PARTNERNot yet recruitingNCT07829146Not applicable
- Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RTNot yet recruitingNCT05937659
- Pharmacologic Therapies to Mitigate Radiation- Associated Heart DiseaseRecruitingNCT07685938Phase 2
- The STRONG Nutrition Support Study for People With Pancreatic CancerNot yet recruitingNCT07826780Not applicable
- Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCCRecruitingNCT06096038Phase 1
- Promoting CT Engagement for Pancreatic Cancer With AppRecruitingNCT06252545Not applicable
- Effects of Infusion Timing on Treatment Response in Solid TumorsRecruitingNCT07630168Phase 2
- Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer StudyRecruitingNCT07214610
- Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AMLNot yet recruitingNCT07605949Phase 2
- A Decision Support Tool for Pancreatic Cancer Screening -Aim 2Not yet recruitingNCT07808671Not applicable
- Brain Slice Explants to Predict Drug Response in Brain TumorsRecruitingNCT05978557
- GRID Therapy for Extremity Soft Tissue SarcomaRecruitingNCT06073067Not applicable
- Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)RecruitingNCT06902311Phase 2
- Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast CancerRecruitingNCT07025785Not applicable
- Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIVNot yet recruitingNCT07624123Not applicable
- Evaluating Narrative Vaping Prevention Video Ads for Adolescents and Young AdultsNot yet recruitingNCT07767929Not applicable
- H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC)Not yet recruitingNCT07484139Phase 2
- Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in KenyaNot yet recruitingNCT07545746Phase 2
- SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical ConsentNot yet recruitingNCT07494994Not applicable
- Overcoming Barriers to Uptake of Cascade ScreeningNot yet recruitingNCT07304063Not applicable
- Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer SurvivorsRecruitingNCT06848491Not applicable
- Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid TumorsRecruitingNCT03454035Phase 1
- Virtual Testis Cancer Lay Support and Survivorship Aim 2Not yet recruitingNCT06702592Not applicable
- A Novel Approach Utilizing Organ Specific Age ProteomicsRecruitingNCT06789653
- Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North CarolinaNot yet recruitingNCT07294066Not applicable
- MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain MetsRecruitingNCT04073966
- DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology ClinicsRecruitingNCT06296368Not applicable
- ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 CellsRecruitingNCT06090864Phase 1/2
- Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK InhibitorsNot yet recruitingNCT07526597Phase 2
- Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)RecruitingNCT07634653Not applicable